PAS
TGTX icon

Point72 Asia (Singapore)’s TG Therapeutics TGTX Stock Holding History

Point72 Asia (Singapore)’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$147K Buy
+4,060
New +$134K 0.02% 364
2024
Q3 		– Sell
-10,166
Closed -$181K – 1316
2024
Q2 		$181K Sell
10,166
-13,580
-57% -$217K 0.04% 323
2024
Q1 		$361K Buy
+23,746
New +$378K 0.09% 237

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Point72 Asia (Singapore)'s TGTX Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in TG Therapeutics (TGTX) in Q3 2025: 4,060 shares worth $147K. The stake represents 0.02% of the portfolio and ranks #364 among its holdings. This is a return to the name: Point72 Asia (Singapore) previously reported a position in TGTX as recently as Q2 2024.

Point72 Asia (Singapore) first reported a position in TGTX in Q1 2024 and has held it in 3 quarters since. The position peaked at $361K in Q1 2024. 354 funds tracked by Wall St. Rank hold TGTX as of Q3 2025.

  • Point72 Asia (Singapore) held 4,060 shares of TG Therapeutics worth $147K as of Q3 2025.
  • TG Therapeutics was a new Point72 Asia (Singapore) position in Q3 2025.
  • TG Therapeutics made up 0.02% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #364 holding.
  • Point72 Asia (Singapore) first reported a position in TG Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • Point72 Asia (Singapore)'s TG Therapeutics position peaked at $361K in Q1 2024.
  • 354 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.